Clinical pearls addressing hair growth and loss in transgender patients on hormone replacement therapy

Chinenye Onejeme, Mary Fitzgibbon, Antonio Jimenez, Lindy Ross

Research output: Contribution to journalArticlepeer-review

Abstract

Hair is a defining feature of human appearance and plays an essential role in personality and identity development. Currently, about 1.6% of US adults identify as transgender. Within the transgender community, hair serves not only as a means of self-expression but also as a crucial element in affirming gender identity, helping individuals to align their outward appearance with their inner sense of self. However, there are significant disparities in the care provided to transgender patients, particularly those seeking a more masculine or feminine appearance through hormone replacement therapy. Studies on transgender patient satisfaction with current therapies are limited but indicate overall dissatisfaction with the standard of care.Dermatologists play a pivotal role in advocating and caring for transgender patients regarding their hair and skin needs. A deeper understanding of hormone replacement therapy and hair growth/loss therapy is crucial to prescribing medications aligned with patients' treatment goals. This commentary aims to provide clinical guidance to dermatologists, aiding them in educating transgender patients undergoing hormone replacement therapy about accessible options for hair growth and loss. Treatment algorithms have been proposed based on efficacy, pharmacodynamic interactions with hormone replacement therapy, cost-effectiveness, adverse reactions, and care accessibility tailored specifically for transfeminine and transmasculine patients.

Original languageEnglish (US)
JournalDermatology online journal
Volume31
Issue number1
DOIs
StatePublished - Jan 2025

Keywords

  • androgen
  • estrogen
  • gender
  • hair
  • hormones
  • transgender

ASJC Scopus subject areas

  • Dermatology

Fingerprint

Dive into the research topics of 'Clinical pearls addressing hair growth and loss in transgender patients on hormone replacement therapy'. Together they form a unique fingerprint.

Cite this